Stockscreener 앱 받기
4.86
3.95%
-0.20
전일 마감가:
$5.06
열려 있는:
$5.03
하루 거래량:
141.35K
Relative Volume:
0.43
시가총액:
$264.43M
수익:
$77.36M
순이익/손실:
$-38.43M
주가수익비율:
-6.5605
EPS:
-0.7408
순현금흐름:
$-29.92M
1주 성능:
-3.38%
1개월 성능:
+22.42%
6개월 성능:
-41.87%
1년 성능:
+38.07%
1일 변동 폭
$4.85
$5.07
1주일 범위
$4.80
$5.17
52주 변동 폭
$3.11
$9.2362
Sight Sciences Inc Stock (SGHT) Company Profile
명칭
Sight Sciences Inc
전화
(415) 889-0550
주소
4040 CAMPBELL AVE,, MENLO PARK
Compare SGHT vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SGHT
Sight Sciences Inc
|
4.86 | 275.31M | 77.36M | -38.43M | -29.92M | -0.7408 |
ABT
Abbott Laboratories
|
85.60 | 150.32B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
305.09 | 117.93B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
73.81 | 97.02B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
48.31 | 72.99B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.47 | 49.50B | 6.30B | 1.07B | 1.09B | 1.8406 |
Sight Sciences Inc Stock (SGHT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-05 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2025-08-08 | 업그레이드 | Lake Street | Hold → Buy |
| 2024-12-06 | 개시 | UBS | Buy |
| 2024-11-04 | 다운그레이드 | Lake Street | Buy → Hold |
| 2024-08-21 | 개시 | Lake Street | Buy |
| 2023-09-12 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2023-09-12 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2023-09-12 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2023-08-24 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2023-07-10 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2023-01-06 | 업그레이드 | Stifel | Hold → Buy |
| 2022-10-04 | 개시 | Needham | Hold |
| 2022-07-26 | 개시 | Stifel | Hold |
| 2022-02-03 | 개시 | William Blair | Outperform |
| 2022-01-07 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
모두보기
Sight Sciences Inc 주식(SGHT)의 최신 뉴스
Sight Sciences (SGHT) Q1 earnings: How key metrics compare to Wall Street estimates - MSN
Sight Sciences Inc. (SGHT) Nears Key Support After 3.95% DeclineTrading Ideas - thelegaladvocate.com
Sight Sciences Inc stock (US8177721062): Nasdaq-listed eye-care player sees muted trading ahead of Q - AD HOC NEWS
SGHT Maintained by Citigroup -- Price Target Raised to $5.15 - GuruFocus
Sight Sciences Drops in Pre-Market Trade as Investors Watch SGHT Growth - Bez Kabli
Sight Sciences | 4: Statement of changes in beneficial ownership of securities-Officer Bauerlein Alison - Moomoo
Sight Sciences wins $34M patent ruling against Alcon - MSN
Sight Sciences Inc. (SGHT) Q1 2026 Earnings: EPS Misses Estimates as Operating Losses WidenEarnings Growth Analysis - Newser
Sight Sciences Inc. (SGHT) Q1 2026 Earnings: Wider-Than-Expected Loss Drags Stock Down Over 2%Tax Rate Impact - Newser
Sight Sciences stock (US8177721062): eye-care specialist in focus after latest business update - AD HOC NEWS
Sight Sciences (SGHT) Q1 2026 Results Disappoint — Multiple Headwinds CitedSocial Buzz Stocks - Newser
Sight Sciences (SGHT) Fell -0.64% — Is a Recovery Ahead? 2026-05-20Sector Neutral Pair - Newser
Sight Sciences (SGHT) Q1 2026 Disappoints — EPS $-0.24 Below $-0.17 ViewsTangible Book Value - newsline.com
Sight Sciences (SGHT) COO sells 12,728 shares to cover RSU tax obligations - Stock Titan
Sight Sciences stock (US8177721062): eye-care specialist in focus after recent earnings and FDA upda - AD HOC NEWS
Sight Sciences appoints Ali Bauerlein as COO and Jim Rodberg as CFO - MSN
Sight Sciences signals $83M-$89M 2026 revenue outlook while targeting $6M-$8M dry eye sales - MSN
sight sciences, inc. Earnings dates - RTTNews
Affiliate plans sale of 12,728 SGHT shares (NASDAQ: SGHT) via Fidelity - Stock Titan
Sight Sciences, Inc. (NASDAQ:SGHT) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
TradingKey - TradingKey
Sight Sciences (SGHT) Climbs +2.86% — Resistance at $5.29 in Focus 2026-05-14Investment Community - Newser
SGHT (Sight Sciences) posts wider-than-expected loss as earnings miss forecasts by 42%, shares dip.Wall Street Picks - Newser
Sight Sciences (SGHT) Q1 Loss Of US$0.24 EPS Tests Margin Improvement Narrative - Sahm
SGHT (Sight Sciences) beats Q1 earnings estimates by 5.1% as shares climb 1.70% on optimism.Trader Community Insights - newser.com
Insiders At Sight Sciences Sold US$1.8m In Stock, Alluding To Potential Weakness - Moomoo
Sight Sciences(SGHT) Stock Options Chain | Quotes & News - Moomoo
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Sight Sciences Financial Results for Q1 2026 Show Growth - VisionMonday.com
Sight Sciences Earnings Call Signals Disciplined Growth - TipRanks
Lake Street Initiates Sight Sciences(SGHT.US) With Buy Rating, Announces Target Price $12 - Moomoo
Sight Sciences, Inc. (NASDAQ:SGHT) Q1 2026 Earnings Call Transcript - Insider Monkey
Needham Maintains Sight Sciences(SGHT.US) With Hold Rating - Moomoo
Piper Sandler Maintains Sight Sciences(SGHT.US) With Buy Rating, Maintains Target Price $9 - Moomoo
Sight Sciences (SGHT) Q1 2026 Earnings Transcript - AOL.com
Sight Sciences Q1 Earnings Call Highlights - Yahoo Finance
Sight Sciences (SGHT) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates - sharewise.com
Sight Sciences, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Sight Sciences Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Sight Sciences, Inc. (SGHT) Reports Q1 Loss, Beats Revenue Estimates - Yahoo Finance
SGHT: Double-digit revenue growth and raised guidance, with strong segment execution and patent win - TradingView
Earnings call transcript: Sight Sciences Q1 2026 revenue up, EPS misses By Investing.com - Investing.com South Africa
Earnings call transcript: Sight Sciences Q1 2026 revenue up, EPS misses - Investing.com
Sight Sciences Lifts 2026 Outlook After Strong Q1 - TipRanks
Sight Sciences (NASDAQ: SGHT) grows Q1 2026 sales and wins $55.4M judgment - Stock Titan
Sight Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Sight Sciences (NASDAQ: SGHT) boosts 2026 revenue outlook after strong Q1 - Stock Titan
BRIEF-Sight Sciences Q1 Revenue USD 19.7 Million Vs. IBES Estimate USD 18.5 Million - TradingView
Sight Sciences Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Revenue Guidance - GlobeNewswire
Sight Sciences Inc expected to post a loss of 17 cents a shareEarnings Preview - TradingView
Sight Sciences Publishes Its 2025 Sustainability Report - VisionMonday.com
Sight Sciences Inc (SGHT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.59%
1.94%
자본화:
|
볼륨(24시간):